论文信息 - Abstract P6-17-02: Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-low expressing breast cancer: Updated results of a large phase 1 study - 字舞流文

Abstract P6-17-02: Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-low expressing breast cancer: Updated results of a large phase 1 study

C. Redfern | H. Iwata | S. Modi | Y. Sagara | I. Krop | Haeseong Park | T. Doi | J. Tsurutani | K. Tamura | R. Redman | A. Moreno-Aspitia | M. Sugihara | S. Takahashi | R. Murthy | Y. Fujisaki | C. Lee